Gene · 3598
Papers2,877
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
641 to 660 of 2,877
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The IL-4/IL-13 signaling axis promotes prostatic fibrosis. | PLoS One | 2022 | 36201508 | PubTator, text mining | PubMed |
| IL-4 receptor blockade is a global repressor of naïve B cell development and responses in a dupilumab-treated patient. | Clin Immunol | 2022 | 36189576 | PubTator, text mining | PubMed |
| Development of immunotherapy for high-grade gliomas: Overcoming the immunosuppressive tumor microenvironment. | Front Med (Lausanne) | 2022 | 36186781 | PubTator, text mining | PubMed |
| Immunotherapy approaches for the treatment of diffuse midline gliomas. | Oncoimmunology | 2022 | 36185807 | PubTator, text mining | PubMed |
| Ligand-based CAR-T cell: Different strategies to drive T cells in future new treatments. | Front Immunol | 2022 | 36172370 | PubTator, text mining | PubMed |
| The roles of small extracellular vesicles in cancer and immune regulation and translational potential in cancer therapy. | J Exp Clin Cancer Res | 2022 | 36167539 | PubTator, text mining | PubMed |
| GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma. | J Immunother Cancer | 2022 | 36167468 | PubTator, text mining | PubMed |
| Transcriptome changes in stages of non-alcoholic fatty liver disease. | World J Hepatol | 2022 | 36158924 | PubTator, text mining | PubMed |
| Bacteria-derived chimeric toxins as potential anticancer agents. | Front Oncol | 2022 | 36158673 | PubTator, text mining | PubMed |
| Recent findings on chimeric antigen receptor (CAR)-engineered immune cell therapy in solid tumors and hematological malignancies. | Stem Cell Res Ther | 2022 | 36153626 | PubTator, text mining | PubMed |
| An integrative bioinformatics investigation and experimental validation of critically involved genes in high-grade gliomas. | Diagn Pathol | 2022 | 36153549 | PubTator, text mining | PubMed |
| Interleukin 13 receptor alpha 2 (IL13Rα2): Expression, signaling pathways and therapeutic applications in cancer. | Biochim Biophys Acta Rev Cancer | 2022 | 36152905 | PubTator, text mining | PubMed |
| Recent Advances in Glioma Cancer Treatment: Conventional and Epigenetic Realms. | Vaccines (Basel) | 2022 | 36146527 | PubTator, text mining | PubMed |
| Brain-Targeted Drug Delivery. | Pharmaceutics | 2022 | 36145583 | PubTator, text mining | PubMed |
| Immunogenic Cell Death Enhances Immunotherapy of Diffuse Intrinsic Pontine Glioma: From Preclinical to Clinical Studies. | Pharmaceutics | 2022 | 36145510 | PubTator, text mining | PubMed |
| Advances in Cancer Diagnosis: Bio-Electrochemical and Biophysical Characterizations of Cancer Cells. | Micromachines (Basel) | 2022 | 36144024 | PubTator, text mining | PubMed |
| Apprising Diagnostic and Prognostic Biomarkers in Cutaneous Melanoma-Persistent Updating. | J Pers Med | 2022 | 36143291 | PubTator, text mining | PubMed |
| An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment. | Cancer Commun (Lond) | 2022 | 36129048 | PubTator, text mining | PubMed |
| CAR-T cell potency: from structural elements to vector backbone components. | Biomark Res | 2022 | 36123710 | PubTator, text mining | PubMed |
| Interrelationship and Sequencing of Interleukins4, 13, 31, and 33 - An Integrated Systematic Review: Dermatological and Multidisciplinary Perspectives. | J Inflamm Res | 2022 | 36110506 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3598/papers?page=33